{"id":1248,"date":"2010-02-04T00:00:00","date_gmt":"2010-02-04T00:00:00","guid":{"rendered":"https:\/\/protherics2.aazzxx.com\/news\/btg-receives-first-european-regulatory-approval-for-digifab\/"},"modified":"2022-09-08T10:05:28","modified_gmt":"2022-09-08T10:05:28","slug":"btg-receives-first-european-regulatory-approval-for-digifab","status":"publish","type":"news","link":"https:\/\/serb.com\/nl\/news\/btg-receives-first-european-regulatory-approval-for-digifab\/","title":{"rendered":"BTG Receives First European Regulatory Approval for DigiFab\u2122"},"content":{"rendered":"<p><em><strong>&#8211; DigiFab\u2122 Approved in Switzerland &#8211;<\/strong><\/em><\/p>\n<p>BTG plc (LSE: BGC), the specialty pharmaceuticals company, today announces that Swissmedic, the Swiss Agency for Therapeutic Products, has approved the antidote DigiFab\u2122 for the treatment of patients with life-threatening digitalis intoxication. DigiFab\u2122 is already available in Switzerland under a conditional marketing authorisation and in other European Countries under named patient programmes.<\/p>\n<p>BTG plc has a licensing agreement with Beacon Pharmaceuticals Ltd for the marketing of DigiFab\u2122 in Europe and Beacon has sub-licensed DigiFab\u2122 distribution in Switzerland to Proreo Pharma AG.<\/p>\n<p>DigiFab\u2122 has been licensed by the US Food and Drug Administration since 2001 and BTG is establishing commercial operations to market DigiFab\u2122 in the US from 1st October 2010. DigiFab\u2122 is currently under review by the MHRA, the UK regulator and by Health Canada, the Canadian regulatory authority. BTG plans to seek additional European approvals in due course via the mutual recognition procedure.<\/p>\n<p>Digoxin, also known as digitalis, is a drug used to treat congestive heart failure and to slow heart rate in some cardiac disturbances. It has a narrow therapeutic window, meaning it is easy to move from therapeutic levels to toxic levels as a result of overdose, slow elimination or interaction with other drugs. DigiFab\u2122 works by binding and neutralising digoxin, facilitating its redistribution away from target tissues and elimination from the body.<\/p>\n<p>Louise Makin, BTG\u2019s CEO, commented: \u201cWe are delighted to announce BTG\u2019s first European approval for DigiFab\u2122. This comes as we continue to progress preparations to market both CroFab\u2122 and DigiFab\u2122 in the US from 1st October 2010.\u201d<\/p>\n<p><strong>For further information contact:<\/strong><\/p>\n<p>BTG<\/p>\n<p>Ashley Tapp, Communications Manager<\/p>\n<p>+44 (0)20 7575 1513;<\/p>\n<p>mobile: +44 (0)7790 811554<\/p>\n<p>Rolf Soderstrom, Chief Financial Officer<\/p>\n<p>+44 (0)20 7575 0000<\/p>\n<p>Financial Dynamics<\/p>\n<p>Ben Atwell<\/p>\n<p>+44 (0)20 7831 3113<\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#8211; DigiFab\u2122 Approved in Switzerland &#8211; BTG plc (LSE: BGC), the specialty pharmaceuticals company, today announces that Swissmedic, the Swiss Agency for Therapeutic Products, has approved the antidote DigiFab\u2122 for the treatment of patients with life-threatening digitalis intoxication. DigiFab\u2122 is already available in Switzerland under a conditional marketing authorisation and in other European Countries under [&hellip;]<\/p>\n","protected":false},"featured_media":0,"template":"","class_list":["post-1248","news","type-news","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BTG Receives First European Regulatory Approval for DigiFab\u2122 - SERB Pharmaceuticals<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/serb.com\/nl\/news\/btg-receives-first-european-regulatory-approval-for-digifab\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BTG Receives First European Regulatory Approval for DigiFab\u2122 - SERB Pharmaceuticals\" \/>\n<meta property=\"og:description\" content=\"&#8211; DigiFab\u2122 Approved in Switzerland &#8211; BTG plc (LSE: BGC), the specialty pharmaceuticals company, today announces that Swissmedic, the Swiss Agency for Therapeutic Products, has approved the antidote DigiFab\u2122 for the treatment of patients with life-threatening digitalis intoxication. DigiFab\u2122 is already available in Switzerland under a conditional marketing authorisation and in other European Countries under [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/serb.com\/nl\/news\/btg-receives-first-european-regulatory-approval-for-digifab\/\" \/>\n<meta property=\"og:site_name\" content=\"SERB Pharmaceuticals\" \/>\n<meta property=\"article:modified_time\" content=\"2022-09-08T10:05:28+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/serb.com\\\/nl\\\/news\\\/btg-receives-first-european-regulatory-approval-for-digifab\\\/\",\"url\":\"https:\\\/\\\/serb.com\\\/nl\\\/news\\\/btg-receives-first-european-regulatory-approval-for-digifab\\\/\",\"name\":\"BTG Receives First European Regulatory Approval for DigiFab\u2122 - SERB Pharmaceuticals\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/serb.com\\\/nl\\\/#website\"},\"datePublished\":\"2010-02-04T00:00:00+00:00\",\"dateModified\":\"2022-09-08T10:05:28+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/serb.com\\\/nl\\\/news\\\/btg-receives-first-european-regulatory-approval-for-digifab\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/serb.com\\\/nl\\\/news\\\/btg-receives-first-european-regulatory-approval-for-digifab\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/serb.com\\\/nl\\\/news\\\/btg-receives-first-european-regulatory-approval-for-digifab\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/serb.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BTG Receives First European Regulatory Approval for DigiFab\u2122\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/serb.com\\\/nl\\\/#website\",\"url\":\"https:\\\/\\\/serb.com\\\/nl\\\/\",\"name\":\"SERB Pharmaceuticals\",\"description\":\"SERB Pharmaceuticals\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/serb.com\\\/nl\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BTG Receives First European Regulatory Approval for DigiFab\u2122 - SERB Pharmaceuticals","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/serb.com\/nl\/news\/btg-receives-first-european-regulatory-approval-for-digifab\/","og_locale":"en_US","og_type":"article","og_title":"BTG Receives First European Regulatory Approval for DigiFab\u2122 - SERB Pharmaceuticals","og_description":"&#8211; DigiFab\u2122 Approved in Switzerland &#8211; BTG plc (LSE: BGC), the specialty pharmaceuticals company, today announces that Swissmedic, the Swiss Agency for Therapeutic Products, has approved the antidote DigiFab\u2122 for the treatment of patients with life-threatening digitalis intoxication. DigiFab\u2122 is already available in Switzerland under a conditional marketing authorisation and in other European Countries under [&hellip;]","og_url":"https:\/\/serb.com\/nl\/news\/btg-receives-first-european-regulatory-approval-for-digifab\/","og_site_name":"SERB Pharmaceuticals","article_modified_time":"2022-09-08T10:05:28+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/serb.com\/nl\/news\/btg-receives-first-european-regulatory-approval-for-digifab\/","url":"https:\/\/serb.com\/nl\/news\/btg-receives-first-european-regulatory-approval-for-digifab\/","name":"BTG Receives First European Regulatory Approval for DigiFab\u2122 - SERB Pharmaceuticals","isPartOf":{"@id":"https:\/\/serb.com\/nl\/#website"},"datePublished":"2010-02-04T00:00:00+00:00","dateModified":"2022-09-08T10:05:28+00:00","breadcrumb":{"@id":"https:\/\/serb.com\/nl\/news\/btg-receives-first-european-regulatory-approval-for-digifab\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/serb.com\/nl\/news\/btg-receives-first-european-regulatory-approval-for-digifab\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/serb.com\/nl\/news\/btg-receives-first-european-regulatory-approval-for-digifab\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/serb.com\/"},{"@type":"ListItem","position":2,"name":"BTG Receives First European Regulatory Approval for DigiFab\u2122"}]},{"@type":"WebSite","@id":"https:\/\/serb.com\/nl\/#website","url":"https:\/\/serb.com\/nl\/","name":"SERB Pharmaceuticals","description":"SERB Pharmaceuticals","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/serb.com\/nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/serb.com\/nl\/wp-json\/wp\/v2\/news\/1248","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/serb.com\/nl\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/serb.com\/nl\/wp-json\/wp\/v2\/types\/news"}],"wp:attachment":[{"href":"https:\/\/serb.com\/nl\/wp-json\/wp\/v2\/media?parent=1248"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}